Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism

By Hardy Adam R.   Hill Darryl J.   Poole Alastair W.  

Platelets, Vol. 16, Iss. 7, 2005-11 ,pp. : 415-429

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic receptor M₃ mediates human gallbladder contraction through voltage-gated Ca²⁺ channels and Rho kinase

By Lee Ming-Che   Yang Ying-Chin   Chen Yen-Cheng   Huang Shih-Che  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 2, 2013-02 ,pp. : 205-212

Informa Healthcare

Access to resources Recommend Favorite

Effects of P2Y₁ and P2Y₁₂ receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets

By Mateos-Trigos G.   Evans R.J.   Heath M.F.  

Platelets, Vol. 13, Iss. 5-6, 2002-08 ,pp. : 285-292

Informa Healthcare

Access to resources Recommend Favorite

GLP-1 receptor agonists in the treatment of Type 2 diabetes

By Ahrén Bo  

Diabetes Management, Vol. 3, Iss. 5, 2013-09 ,pp. : 401-413

Future Medicine

Access to resources Recommend Favorite

The P2Y1 receptor is essential for ADP-induced shape change and aggregation in mouse platelets

By Kim Young B.   Jin Jianguo   Dangelmaier Carol   Daniel James L.   Kunapuli Satya P.  

Platelets, Vol. 10, Iss. 6, 1999-12 ,pp. : 399-406

Informa Healthcare

Access to resources Recommend Favorite